{"version":"1.0","type":"link","title":"Repurposing FDA-Approved Agents to Develop a Prototype  Shikimate Kinase (HPSK) Inhibitor: A Computational Approach Using Virtual Screening, MM-GBSA Calculations, MD Simulations, and DFT Analysis.","author_name":"Al Khzem AH 외","author_url":"https://prs-insight.online/author/Al%20Khzem%20AH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/128403","thumbnail_width":1200,"thumbnail_height":630}